Viewing StudyNCT04249843



Ignite Creation Date: 2024-05-06 @ 2:11 PM
Last Modification Date: 2024-10-26 @ 1:27 PM
Study NCT ID: NCT04249843
Status: RECRUITING
Last Update Posted: 2024-01-05
First Post: 2020-01-21

Brief Title: Study of Safety Pharmacokinetics and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors
Sponsor: MapKure LLC
Organization: MapKure LLC

Conditions & Keywords Data

Conditions:
Name
B-Raf Mutation-Related Tumors
Solid Tumor
Keywords:
Name View
BGB3245 View
BRAF inhibitor View
BRAF View
KRAS View
NRAS View
Mitogen Activated Protein Kinase MAPK Pathway View
BRAF fusion View
BRAF Class II View